This Special Issue of Pharmaceuticals describes recent advances accomplished in the field of antifungal development, especially the discovery of new drugs and drug repurposing [...
Traditionally, many invasive fungal infections were associated with a poor prognosis, because effect...
Pathogenic antibiotic resistant bacteria pose one of the most important health challenges of the 21s...
Fungal infections of skin are most common dermatological problems in this world. It has been investi...
This Special Issue is designed to highlight the latest research and development on new antifungal co...
This reprint describes recent advances made in the field of antifungal development, especially the d...
The utility of clinically available antifungals is limited by their narrow spectrum of activity, hig...
Recent investigations have yielded both profound insights into the mechanisms required by pathogenic...
Background: Fungi are the most insidious pathogens, since they are eukaryotic microorganisms. System...
Fungal infections such as candidoses can range from superficial mucous membrane infection to life-th...
Click on the DOI link to access the article (may not be free).New data suggest that the global incid...
With the relentless increase in invasive fungal infections, particularly in critically ill and immun...
PubMedID: 27837500By definition, an antifungal agent is a drug that selectively destroys fungal path...
The invasive fungal infections are among the leading causes of morbidity, mortality and economic bur...
In 1999 the number of new compounds reported in the anti-infective ®eld decreased sig-ni®cantly in c...
Clinically available antifungals have a restricted range of efficacy, substantial toxicity, and emer...
Traditionally, many invasive fungal infections were associated with a poor prognosis, because effect...
Pathogenic antibiotic resistant bacteria pose one of the most important health challenges of the 21s...
Fungal infections of skin are most common dermatological problems in this world. It has been investi...
This Special Issue is designed to highlight the latest research and development on new antifungal co...
This reprint describes recent advances made in the field of antifungal development, especially the d...
The utility of clinically available antifungals is limited by their narrow spectrum of activity, hig...
Recent investigations have yielded both profound insights into the mechanisms required by pathogenic...
Background: Fungi are the most insidious pathogens, since they are eukaryotic microorganisms. System...
Fungal infections such as candidoses can range from superficial mucous membrane infection to life-th...
Click on the DOI link to access the article (may not be free).New data suggest that the global incid...
With the relentless increase in invasive fungal infections, particularly in critically ill and immun...
PubMedID: 27837500By definition, an antifungal agent is a drug that selectively destroys fungal path...
The invasive fungal infections are among the leading causes of morbidity, mortality and economic bur...
In 1999 the number of new compounds reported in the anti-infective ®eld decreased sig-ni®cantly in c...
Clinically available antifungals have a restricted range of efficacy, substantial toxicity, and emer...
Traditionally, many invasive fungal infections were associated with a poor prognosis, because effect...
Pathogenic antibiotic resistant bacteria pose one of the most important health challenges of the 21s...
Fungal infections of skin are most common dermatological problems in this world. It has been investi...
DOI
Add to ORKG